Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
To subscribe to The Bloodline with LLS, click here.
Navajo Nation: The First Cancer Center on a Reservation
Join us as we speak to Dr. Johanna DiMento and Dr. Frank Dalichow, oncologists at the first cancer center on a reservation in the United States. In this episode, the doctors share about the realities of cancer care for Native American communities. They also discuss how they were able to bring cancer care to the Navajo and Hopi tribes, and the importance of inclusivity and culturally appropriate care for this population.
I Will Survive: A Viral TikTok Star's Journey through Acute Lymphoblastic Leukemia (ALL)
Join us as we speak to William Yank, a 23-year-old, three-time Acute Lymphoblastic Leukemia (ALL) survivor. In this episode, we hear about the variety of treatments William went through, his relapses and then subsequent stem cell transplant. Now one year out of transplant, he shares about his post-cancer journey – going viral on TikTok, becoming the face of the LLS Giving Tuesday campaign and then starting a podcast with another Young Adult Cancer survivor.
Support for this episode provided by Amgen Inc. and Jazz Pharmaceuticals.
Exploring Minimal/Measurable Residual Disease (MRD)
Join us as we speak to Dr. Lori Muffly and Dr. Matthew Frank from Stanford Medicine in Stanford, CA, about the recent advancements in testing for Minimal/Measurable Residual Disease (MRD). In this episode, we delve into what MRD is, which blood cancers the testing is currently used on, and how we can utilize it to more accurately monitor patients and customize treatment. The doctors also share exciting possibilities on how MRD and other testing can benefit patients in the future.
Support for this episode provided by Genentech, Inc. & Biogen.
Support for The Bloodline with LLS provided by Amgen; AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals; Kite, A Gilead Company; Novartis; Pharmacyclics, an AbbVie company and Janssen Biotech; Seattle Genetics and Takeda Oncology.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the medical advice of your healthcare provider, information provided to you by your insurance carrier, or to provide legal advice with respect to the subject matter addressed in the podcast.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.